Business · 24/01/2011Updated: 10/17/2026 · 1 min read
FDA Reopens Comment Period for Generic Drug User Fee Program
Summary
The FDA is extending the public comment period for the generic drug user fee program until February 23, 2011, to allow for consideration of late-received comments and public input on the matter.
Original source language: Federal Register — Health and Human ServicesOpen original release →